Metraipolis › archive › dc_487935eef4a6
Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2… — Europe PMC PMID:41888667
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41888667
- DOI
- 10.1186/s11689-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T20:41:50.193Z
- SHA-256 of the archived text
7fc18bf7d6c8008e80651bc16549afa8a815941c9a5934b54c42aaf681a3fecc- Stable URL of this page
https://metraipolis.com/documento/dc_487935eef4a6
How to cite
Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2… — Europe PMC PMID:41888667 — Europe PMC (en), https://europepmc.org/article/MED/41888667 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_487935eef4a6 (Metraipolis archive dc_487935eef4a6, sha256 7fc18bf7d6c8008e80651bc16549afa8a815941c9a5934b54c42aaf681a3fecc)
BibTeX
@misc{dc487935eef4a6,
title = {Phase 2, open-label INSPIRE trial to assess the tolerability and effectiveness of transdermal cannabidiol gel in children and adolescents with 22q11.2… — Europe PMC PMID:41888667},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41888667},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_487935eef4a6; sha256 7fc18bf7d6c8008e80651bc16549afa8a815941c9a5934b54c42aaf681a3fecc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41888667. Agents can read the archived copy with the MCP tool read_document.